Market revenue in 2023 | USD 3.2 million |
Market revenue in 2030 | USD 6.7 million |
Growth rate | 11.2% (CAGR from 2023 to 2030) |
Largest segment | Neurology |
Fastest growing segment | Orthopedic |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dental, Orthopedic, Neurology |
Key market players worldwide | GlaxoSmithKline, Hewlett Packard Enterprise Co, Merck KGaA, AstraZeneca PLC, Aprecia Pharmaceuticals, Extend Biosciences, BioDuro, Affini-T Therapeutics, Osmotica Pharmaceutical, FabRx, Cycle Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 3d printed drugs market will help companies and investors design strategic landscapes.
Neurology was the largest segment with a revenue share of 50% in 2023. Horizon Databook has segmented the Middle East & Africa 3d printed drugs market based on dental, orthopedic, neurology covering the revenue growth of each sub-segment from 2018 to 2030.
Middle Eastern countries such as Saudi Arabia, Qatar, UAE, Kuwait, and Oman are prospering economies. Advancements in the healthcare system are expected to increase the demand for 3D printed drugs in MEA. Furthermore, various initiatives, such as the National Transformation Program of Dubai, which is aimed at fully privatizing healthcare facilities to improve healthcare quality, are expected to drive market growth.
The increase in research activities related to using 3D printing technologies in healthcare is another factor expected to boost market growth. Governments and private entities in the region increasingly recognize the potential of 3D printing in drug manufacturing, boosting investments and encouraging innovation.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa 3d printed drugs market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa 3d printed drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account